Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Apoptogen, Exogen merge, form CNS drug co. Aegera

Executive Summary

Private Canadian biotech start-ups Apoptogen and Exogen Neurosciences will merge to form a new company called Aegera Therapeutics Inc., which will develop therapeutics for cancer and neurodegenerative diseases such as Parkinson's and Alzheimer's.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies